Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Published in: American Journal of Clinical Dermatology 3/2017

01-06-2017 | Therapy in Practice

Review and Management of Acneiform Eruptions in Patients with Immune Disorders

Authors: Priyanka Vedak, Jessica St John, Daniela Kroshinsky

Published in: American Journal of Clinical Dermatology | Issue 3/2017

Login to get access

Abstract

Immune disorders are associated with acne or acneiform lesions secondary to the occurrence of acne vulgaris or acneiform eruptions arising as a result of immunosuppressive medication or infection. In this review, we aim to provide an overview of acne and acneiform eruptions that can arise in the immunosuppressed host. Tips for differentiating between various acneiform entities are discussed, as well as a brief overview of treatment considerations.
Literature
1.
Mahé E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF, et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005;79(4):476–82.CrossRefPubMed
2.
Momin SB, Peterson A, Del Rosso JQ. A status report on drug-associated acne and acneiform eruptions. J Drugs Dermatol. 2010;9(6):627–36.PubMed
3.
Du-Thanh A, Kluger N, Bensalleh H, Guillot B. Drug-induced acneiform eruption. Am J Clin Dermatol. 2011;12(4):233–45.CrossRefPubMed
4.
Ayers K, Sweeney SM, Wiss K. Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med. 2005;159(1):64–7.CrossRefPubMed
5.
Tragiannidis A, Bisping G, Koehler G, Groll AH. Minireview: malassezia infections in immunocompromised patients. Mycoses. 2010;53(3):187–95.CrossRefPubMed
6.
Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51(5):785–98.CrossRefPubMed
7.
Alves EV, Martins JE, Ribeiro EB, Sotto MN. Pityrosporum folliculitis: renal transplantation case report. J Dermatol. 2000;27(1):49–51.CrossRefPubMed
8.
Bufill JA, Lum LG, Caya JG, Chitambar CR, Ritch PS, Anderson T, et al. Pityrosporum folliculitis after bone marrow transplantation. Clinical observation in five patients. Ann Intern Med. 1988;108(4):560–3.CrossRefPubMed
9.
Parsad D, Saini R, Negi KS. Short-term treatment of Pityrosporum folliculitis: a double blind placebo-controlled study. J Eur Acad Dermatol Venereol. 1998;11:188–90.CrossRefPubMed
10.
11.
Lee JW, Kim BJ, Kim MN. Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg Med. 2010;42(2):192–6.CrossRefPubMed
12.
Kick G, Korting HC. Debilitating folliculitis barbae candidomycetica in a trumpeter: successful treatment with fluconazole. Mycoses. 1998;41(7–8):339–42.CrossRefPubMed
13.
Süss K, Vennewald I, Seebacher C. Case report. Folliculitis barbae caused by Candida albicans. Mycoses. 1999;42(11–12):683–5.CrossRefPubMed
14.
Darcis JM, Etienne M, Demonty J, Christophe J, Pierard GE. Candida albicans septicemia with folliculitis in heroin addicts. Am J Dermatopathol. 1986;8(6):501–4.CrossRefPubMed
15.
Kapdağli H, Oztürk G, Dereli T, Inci R, Hilmioğlu Z, Kazandi AC, et al. Candida folliculitis mimicking tinea barbae. Int J Dermatol. 1997;36(4):295–7.CrossRefPubMed
16.
Delfos NM, Collen AF, Kroon FP. Demodex folliculitis: a skin manifestation of immune reconstitution disease. AIDS. 2004;18(4):701–2.CrossRefPubMed
17.
Nagakawa T, Sasaki M, Fujita K, Nishimoto M, Takaiwa T. Demodex folliculitis on the trunk of a patient with mycosis fungoides. Clin Exp Dermatol. 1996;21(2):148–50.CrossRef
18.
Cotlair J, Frankfurt O. Demodex folliculitis mimicking acute graft-vs-host disease. JAMA Dermatol. 2013;149(12):1407–9.CrossRef
19.
Herron MD, Orielly MA, Vanderhooft SL. Refractory Demodex folliculitis in five children with acute lymphoblastic leukemia. Pediatr Dermatol. 2005;22(5):407–11.CrossRefPubMed
20.
Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60(3):453–62.CrossRefPubMed
21.
Purcell SM, Hayes TJ, Dixon SL. Pustular folliculitis associated with Demodex folliculorum. J Am Acad Dermatol. 1986;15(5 Pt 2):1159–62.CrossRefPubMed
22.
23.
Weinburg JM, Mysliwiec A, Turiansky GW, Redfield R, James WD. Viral folliculitis. Atypical presentations of herpes simplex, herpes zoster, molluscum contagiosum. Arch Dermatol. 1997;133(8):983–6.CrossRef
24.
Jang KA, Kim SH, Choi JH, Sung KJ, Moon KC, Koh JK. Viral folliculitis on the face. Br J Dermatol. 2000;142(3):555–9.CrossRefPubMed
25.
26.
Feldmeyer L, Kamarashev J, Boehler A, Irani S, Speich R, French LE, et al. Molluscum contagiosum folliculitis mimicking tinea barbae in a lung transplant recipient. J Am Acad Dermatol. 2010;63(1):169–71.CrossRefPubMed
27.
Takamura S, Teraki Y. Eosinophilic pustular folliculitis associated with hematological disorders: a report of two cases and review of Japanese literature. J Dermatol. 2016;43(4):432–5.CrossRefPubMed
28.
Laing ME, Laing TA, Mulligan NJ, Keane FM. Eosinophilic pustular folliculitis induced by chemotherapy. J Am Acad Dermatol. 2006;54(4):729–30.CrossRefPubMed
29.
Nomura T, Katoh M, Yamamoto Y, Miyachi Y, Kabashima K. Eosinophilic pustular folliculitis: a proposal of diagnostic and therapeutic algorithms. J Dermatol. 2016;43(11):1301–6.CrossRefPubMed
30.
Blauvelt A, Plott RT, Spooner K, Stearn B, Davey RT, Turner ML. Eosinophilic folliculitis associated with the acquired immunodeficiency syndrome responds well to permethrin. Arch Dermatol. 1995;131(3):360–1.CrossRefPubMed
31.
Hasegawa A, Kobayashi N, Fukumoto T, Asada H. A case of eosinophilic pustular folliculitis with response to infliximab. J Am Acad Dermatol. 2012;67(4):e136–7.CrossRefPubMed
32.
33.
Laroche A, Allard C, Chababi-Atallah M, Masse M, Bertrand J. Trichodysplasia spinulosa in a renal transplant patient. J Cutan Med Surg. 2015;19(1):66–8.CrossRefPubMed
34.
35.
Sadler GM, Halbert AR, Smith N, Rogers M. Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Aust J Dermatol. 2007;48(2):110–4.CrossRef
36.
Böni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003;4(4):273–6.CrossRefPubMed
37.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15 (quiz 16-8).CrossRefPubMed
38.
Monk B, Cunliffe WJ, Layton AM, Rhodes DJ. Acne induced by inhaled corticosteroids. Clin Exp Dermatol. 1993;18(2):148–50.CrossRefPubMed
39.
Plewig G, Kligman AM. Induction of acne by topical steroids. Arch Dermatol Forsch. 1973;247(1):29–52.CrossRefPubMed
40.
Yu HJ, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol. 1998;37(10):772–7.CrossRefPubMed
41.
Giavedoni P, Mascaró-Galy JM, Aguilera P, Estrach-Panella T. Acne fulminans successfully treated with cyclosporine and isotretinoin. J Am Acad Dermatol. 2014;70(2):e38–9.CrossRefPubMed
42.
Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol. 2005;16(9):1425–33.CrossRefPubMed
43.
Sipples R. Common side effects of anti-EGFR therapy: acneform rash. Semin Oncol Nurs. 2006;22(1 Suppl 1):28–34.CrossRefPubMed
44.
Duvic M. EGFR inhibitor-associated acneiform folliculitis: assessment and management. Am J Clin Dermatol. 2008;9(5):285–94.CrossRefPubMed
45.
Amitay-Laish I, David M, Stemmer SM. Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions. Oncologist. 2010;15(9):1002–8.CrossRefPubMedPubMedCentral
46.
Micantonio T, Fargnoli MC, Ricevuto E, Ficorella C, Marchetti P, Peris K. Efficacy of treatment with tetracyclines to prevent acneiform eruptions secondary to cetuximab therapy. Arch Dermatol. 2005;141(9):1173–4.CrossRefPubMed
47.
Bachet JB, Peuvrel L, Bachmeyer C, Reguiai Z, Gourraaud PA, Bouche O, et al. Folliculitis induced by EGFR inhibitors, preventative and curative efficacy of tetracyclines in the management and incidence rates according to type of EGFR inhibitor administered: a systemic literature review. Oncologist. 2012;17(4):555–68.CrossRefPubMedPubMedCentral
48.
Chiang HC, Anadkat MJ. Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions. J Am Acad Dermatol. 2013;69(4):657–8.CrossRefPubMed
49.
Scope A, Agero AL, Dusza SW, Myskowski PL, Lieb JA, Saltz L, et al. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol. 2007;25(34):5390–6.CrossRefPubMed
50.
Scope A, Lieb JA, Dusza SW, Phelan DL, Myskowski PL, Saltz L, et al. A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption. J Am Acad Dermatol. 2009;61(4):614–20.CrossRefPubMed
51.
Alexandrescu DT, Vaillant JG, Dasanu CA. Effect of treatment with colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors. Clin Exp Dermatol. 2007;32(1):71–4.PubMed
52.
Tomkova H, Pospiskova M, Zabojnikova M, Kohoutek M, Serclova M, Gharibyar M, et al. Phytomenadione pre-treatment in EGFR inhibitor-induced folliculitis. J Eur Acad Dermatol Venereol. 2013;27(4):514–9.CrossRefPubMed
53.
54.
Petukhova TA, Navoa RA, Honda K, Koon HB, Gerstenblith MR. Acneiform eruptions associated with vemurafinib. J Am Acad Dermatol. 2013;68(3):e97–9.CrossRefPubMed
55.
56.
Fleta-Asin B, Vano-Galvan S, Ledo-Rodriguez A, Truchuelo-Diez M, Jaen-Olasolo P. Facial acneiform rash associated with sorafenib. Dermatol Online J. 2009;15(4):7.PubMed
57.
Anforth R, Liu M, Nguyen B, Uribe P, Kefford R, Clements A, et al. Aceniform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib. Aust J Dermatol. 2014;55(3):250–4.CrossRef
58.
Adelson K, Kim SS. Severe acneiform eruption following trastuzumab therapy. J Hematol Oncol Pharm. 2011;1(1).
59.
Sheu J, Hawryluk EB, Litsas G, Thakuria M, LeBoeuf NR. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor. Clin Breast Cancer. 2015;15(1):e77–81.CrossRefPubMed
60.
el-Shahawy MA, Gadallah MF, Massry SG. Acne: a potential side effect of cyclosporine A therapy. Nephron. 1996;72(4):679–82.CrossRefPubMed
61.
Piaserico S, Fortina AB, Cavallini F, Alaibac M. Acne keloidalis of the scalp in a renal transplant patient treated with cyclosporine. Acta Derm Venereol. 2009;89(3):312–3.CrossRefPubMed
62.
Azurdia RM, Graham RM, Weismann K, Guerin DM, Parslew R. Acne keloidalis in caucasian patients on cyclosporin following organ transplantation. Br J Dermatol. 2000;143(2):465–7.CrossRefPubMed
63.
Mahe E, Morelon E, Lechaton S, Drappier JC, de Prost Y, Kreis H, et al. Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiolgical, histological, therapeutic and pathogenic aspects. J Am Acad Dermatol. 2006;55(1):139–42.CrossRefPubMed
64.
Kunzle N, Venetz JP, Pascual M, Panizzon RG, Laffitte E. Sirolimus-induced acneiform eruption. Dermatology. 2005;211(4):366–9.CrossRefPubMed
65.
Bassi E, Poli F, Charachon A, Claudepierre P, Revuz J. Infliximab-induced acne: report of two cases. Br J Dermatol. 2007;156(2):402–3.CrossRefPubMed
66.
Kashat M, Caretti K, Kado J. Etanercept-induced cystic acne. Cutis. 2014;94(1):31–2.PubMed
67.
Campione E, Mazzotta AM, Bianchi L, Chimenti S. Severe acne successfully treated with etanercept. Acta Derm Venereol. 2006;86(3):256–7.CrossRefPubMed
68.
Vedak P, Kroshinsky D, St John J, Xavier RJ, Yajnik V, Ananthakrishnan AN. Genetic basis of TNF-α antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysis. Aliment Pharmacol Ther. 2016;43(6):697–704.CrossRefPubMedPubMedCentral
69.
Michot C, Guillot B, Dereure O. Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents. Dermatology. 2010;220(1):49–50.CrossRefPubMed
70.
Andreu-Barasoain M, Gomez de la Fuente E, Pinedo F, Nuno A, Lopez-Estebaranz JL. Intravesical mitomycin-C induced generalized pustular folliculitis. J Am Acad Dermtol. 2012;67(4):e142–3.CrossRef
71.
Bellman BA, Eaglstein WH, Miller J. Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. Transplantation. 1996;61(1):173.CrossRefPubMed
72.
Shapiro LE, Shear NH. Drug interactions: proteins, pumps, and P-450s. J Am Acad Dermatol. 2002;47(4):467–84 (quiz 485–8).CrossRefPubMed
73.
Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malasezzia folliculitis with fluconazole in orthotopic heart transplant patients. J Heart Lung Transplant. 2000;19(2):215–9.CrossRefPubMed
74.
Keogh A, Spratt P, McCosker C, Macdonald P, Mundy J, Kaan A. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med. 1995;333(10):628–33.CrossRefPubMed
75.
Endo JO, Wong JW, Norman RA, Chang AL. Geriatric dermatology: part I. Geriatric pharmacology for the dermatologist. J Am Acad Dermatol. 2013;68(4):521.e1–10 (quiz 531–2).CrossRef
76.
Bienvenu B, Martinez F, Devergie A, Rybojad M, Rivet J, Bellenger P, et al. Topical use of cidofovir induced acute renal failure. Transplantation. 2002;73(4):661–2.CrossRefPubMed
Metadata
Title
Review and Management of Acneiform Eruptions in Patients with Immune Disorders
Authors
Priyanka Vedak
Jessica St John
Daniela Kroshinsky
Publication date
01-06-2017
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 3/2017
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-017-0256-2

Other articles of this Issue 3/2017

American Journal of Clinical Dermatology 3/2017 Go to the issue

Review Article

Tranexamic Acid in the Treatment of Melasma: A Review of the Literature

Review Article

Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment

Evidence-Based Review

The Role of Photodynamic Therapy in Acne: An Evidence-Based Review

Current Opinion

Next-Generation Sequencing to Guide Treatment of Advanced Melanoma

Original Research Article

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study

short communication

Immunostaining for High-Risk Human Papillomavirus in Condyloma Lesions in Immunocompromised Patients